News Quantified

AYTU – aytu biopharma, inc. (US:NASDAQ)

Aytu BioPharma (AYTU) was downgraded by Zacks Research from "hold" to "strong sell".

3/4

05:50 am

aytu

Low

Aytu BioPharma (AYTU) was upgraded by Zacks Research from "strong sell" to "hold".

Aytu BioPharma Inc (AYTU) Q2 2026 Earnings Call Highlights: Navigating Challenges and ... [Yahoo! Finance]

Aytu BioPharma, Inc. (AYTU) Q2 2026 Earnings Call Transcript [Seeking Alpha]

Aytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue Estimates [Yahoo! Finance]

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}